Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Latest News

CLL cells magnified/stained | image credit: jarun011 - stock.adobe.com
6-Year Data Support Fixed-Duration Ven-Obi for Untreated CLL

December 10th 2024

Long-term data support the safety and efficacy of venetoclax (Venclexta) and obinutuzumab (Gazyva) in chronic lymphocytic leukemia (CLL), though questions remain about which patients would benefit most from the regimen.

Guidelines folder-tashatuvango-stock.adobe.com.jpeg
New Guidelines Clarify EORTC Quality of Life Scores for Chronic Lymphocytic Leukemia

December 2nd 2024

New evidence suggest a slight connection between receiving a tattoo and elevated cancer risks | image credit: xartproduction - stock.adobe.com
Tattoos May Be Associated With Increased Risk of Rare NHLs

November 29th 2024

Big Data | Image Credit: © Friends Stock-stock.adobe.com
Real-World Data Confirm Ibrutinib's Role in Relapsed CLL

November 26th 2024

Older woman taking out dose of pills from glass bottle | Image Credit: © fizkes - stock.adobe.com
Novel Relapsed/Refractory CLL Therapies Have Similar Safety Profiles

November 23rd 2024

More News

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo